| Secondary | Intra Operative Hemorrhage | Calculate the number of coagulators for the intra operative hemorrhage. | | Posted | | Mean | Standard Deviation | coagulators | | End of the surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| | | Title | Denominators | Categories |
|---|
| | | Title | Measurements |
|---|
| - OG0000.63± 1.0
- OG0011.3± 1.4
|
|
| | Group IDs | Group Description | Statistical Method | Statistical Comment | P-Value | P-Value Comment | Parameter Type | Parameter Value | Dispersion Type | Dispersion Value | Confidence Interval Sides | Confidence Interval % | CI Lower Limit | CI Upper Limit | CI Lower Limit Comment | CI Upper Limit Comment | Estimate Comment | Tested Non-Inferiority | Non-Inferiority Type | Non-Inferiority Comment | Other Analysis Description |
|---|
| | Wilcoxon (Mann-Whitney) | | 0.025 | | | | | | | | | | | | | No | Superiority or Other | | |
|
| Secondary | Postoperative Vitreous Hemorrhage. | Postoperative vitreous hemorrhage that is permitted within 4 weeks after surgery. | | Posted | | Number | | participants | | 1 month | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Primary | Reoperation | Vitreoretinal reoperation due to recurrent vitreous hemorrhage. | | Posted | | Number | | participants | | 1 month | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Vascular Endothelial Growth Factor Concentration in Vitreous | Vascular endothelial growth factor concentration in vitreous at the start of vitrectomy. | | Posted | | Mean | Standard Deviation | μg/ml | | Start of surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Endolaser Photocoagulation | Number of intraoperative endolaser photocoagulation. | | Posted | | Mean | Standard Deviation | photocoagulation | | End of surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Iatrogenic Retinal Tears | The number of participants who had intraoperative iatrogenic retinal tears. | | Posted | | Number | | participants | | End of surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Surgical Time | | | Posted | | Mean | Standard Deviation | minutes | | End of surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Postoperative Best Corrected Visual Acuity | Best corrected visual acuity was measured using the Landolt ring chart, and the result was converted to logMAR notation for analysis. The minimum of the scale is 2.0 and the maximum of the scale is -0.3. The higher values represent a worse outcome. | | Posted | | Mean | Standard Deviation | LogMAR | | 1 mouth after surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Best Corrected Visual Acuity Change | Best corrected visual acuity change was calculated by postoperative logMAR visual acuity minus preoperative logMAR visual acuity. The higher values represent a worse outcome. | | Posted | | Mean | Standard Deviation | LogMAR | | 1 month | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Postoperative Neovascular Glaucoma | The number of participants with progressive or persistent neovascular glaucoma after surgery. | | Posted | | Number | | participants | | Within 1 month after the surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab Injection and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Elevated Intraocular Pressure | The number of participants with elevated intraocular pressure after surgery. | | Posted | | Number | | participants | | Within 1 month after the surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab Injection and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Gas Tamponade | The number of participants with gas tamponade at the end of the surgery. | | Posted | | Number | | participants | | End of surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab Injection and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |
| Secondary | Silicon Oil Tamponade | The number of participants with silicon oil tamponade at the end of the surgery. | | Posted | | Number | | participants | | End of surgery. | | | | ID | Title | Description |
|---|
| OG000 | Bevacizumab Injection and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | | OG001 | Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy |
| |